On Friday, the FDA expanded its approved use of Afrezza for kids six years and older

Hinzugefügt: 2026-06-02

[00:00:00]Well, the FDA has approved an needle-free insulin treatment for pediatric patients with diabetes 6 years and older. The drug is called Afrezza, and it was previously approved for use in adults only. Afrezza is an inhaled, it's meant for meal times only, and of course this makes it much easier for most kids. Doctors tell ABC News it allows more choices in diabetes management. We do need to mention though it does not eliminate the use of needles for those with type 1 diabetes or for people with asthma and other lung conditions with.